Detailed View
MBX - MBX Biosciences, Inc.
Latest filing: 2025-12-31 | Reporting: gaap
Market Cap
1,288,696,192
Adj EBIT (TTM)
-98,055,000
Enterprise Value
914,991,192
Last Price
28.70
Earnings Yield
-10.72%
Return on Capital
-26.53%
Capital
369,649,000
1Y Price Chart
Last Price: $28.70
1Y Change: 240.86%
As of 2026-03-18 | 1Y Change: 240.86%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -25,795,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -23,926,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -21,805,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -26,529,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -19,612,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.